These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34219307)

  • 1. Anxiety and depression status prior to radiotherapy in patients with nasopharyngeal carcinoma and its effect on acute radiation toxicities.
    Li R; Su L; Hua Y; Ye JR; Song XR; Tian J; Song JH; Hong JS
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13487. PubMed ID: 34219307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nutritional status before radiotherapy on radiation-induced acute toxicities in patients with nasopharyngeal carcinoma.
    Song X; Su L; Lin Q; Liu S; Zhang W; Hong J
    Head Neck; 2023 Mar; 45(3):620-628. PubMed ID: 36600471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The psychological status in patients with nasopharyngeal carcinoma during radiotherapy.
    Wang C; Chen J; Su L; Hua Y; Ye J; Song X; Lv W; Zhang M; Huang F; Tian J; Hong J
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1035-1042. PubMed ID: 34110454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of psychological condition before radiotherapy on prognosis in 390 patients initially treated for nasopharyngeal carcinoma.
    Chen J; Hua Y; Su L; Wang C; Zhang H; Ye J; Song X; Li R; Tian J; Zhang W; Hong J
    Support Care Cancer; 2021 Oct; 29(10):5967-5972. PubMed ID: 33765206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
    So N; McDowell LJ; Lu L; Xu W; Rock K; Waldron J; Bernstein LJ; Chan HB; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):134-145. PubMed ID: 31568813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
    Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
    Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
    Zeng L; Tian YM; Sun XM; Chen CY; Han F; Xiao WW; Deng XW; Lu TX
    Br J Cancer; 2014 Jan; 110(1):49-54. PubMed ID: 24253503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
    McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury.
    Tang Y; Luo D; Rong X; Shi X; Peng Y
    PLoS One; 2012; 7(6):e36529. PubMed ID: 22701557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT.
    Ozdemir S; Akin M; Coban Y; Yildirim C; Uzel O
    Asian Pac J Cancer Prev; 2015; 16(5):1897-900. PubMed ID: 25773841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
    Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
    Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function, mood, and sleep quality in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer: a prospective study.
    Mo YL; Li L; Qin L; Zhu XD; Qu S; Liang X; Wei ZJ
    Psychooncology; 2014 Oct; 23(10):1185-91. PubMed ID: 24729515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.